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Abstract. 
 
ADP-ribosylation factor appears to regulate 
the budding of both COPI and clathrin-coated trans-
 
port vesicles from Golgi membranes. An 
 
arf1
 
D
 
 syn-
thetic lethal screen identiﬁed 
 
SWA3/DRS2
 
, which
encodes an integral membrane P-type ATPase and po-
tential aminophospholipid translocase (or ﬂippase). 
The 
 
drs2
 
 null allele is also synthetically lethal with 
clathrin heavy chain (
 
chc1
 
) temperature-sensitive alle-
les, but not with mutations in COPI subunits or other 
 
SEC
 
 genes tested. Consistent with these genetic analy-
ses, we found that the 
 
drs2
 
D
 
 mutant exhibits late Golgi 
defects that may result from a loss of clathrin function 
at this compartment. These include a defect in the 
 
Kex2-dependent processing of pro–
 
a
 
-factor and the ac-
cumulation of abnormal Golgi cisternae. Moreover, we 
observed a marked reduction in clathrin-coated vesicles 
that can be isolated from the 
 
drs2
 
D
 
 cells. Subcellular 
fractionation and immunoﬂuorescence analysis indicate 
that Drs2p localizes to late Golgi membranes contain-
ing Kex2p. These observations indicate a novel role for 
a P-type ATPase in late Golgi function and suggest a 
possible link between membrane asymmetry and clath-
rin function at the Golgi complex.
Key words: adenosine diphosphate–ribosylation fac-
tor • aminophospholipid translocase • clathrin • DRS2 
• trans-Golgi network
 
T
 
HE
 
 directed movement of proteins between com-
partments of the secretory and endocytic pathways
is driven by the formation of small coated transport
vesicles that bud from a donor compartment, and then
fuse with an acceptor compartment. COPI, COPII, and
clathrin are the best characterized coat proteins involved
in protein transport. COPI, a heptameric (
 
a
 
, 
 
b
 
, 
 
b9
 
, 
 
g
 
, 
 
d
 
, 
 
e
 
,
 
z
 
-COP) protein complex, coats vesicles that mediate pro-
tein transport from the Golgi to the ER and possibly
between Golgi compartments. To initiate budding of COPI-
coated vesicles from Golgi membranes, the small GTP-
binding protein ADP-ribosylation factor (ARF)
 
1
 
 mediates
the recruitment of COPI coats to primarily cis Golgi cis-
ternae. ARF is also required to recruit clathrin/AP-1 coats
to the trans-Golgi network. Clathrin coats are assembled
from triskelions composed of three clathrin heavy chains
and three light chains. The tetrameric adaptor protein
(AP) complex, AP-1, links membrane proteins to clathrin
at the TGN and appears to facilitate cargo delivery to en-
dosomal compartments (reviewed in Schmid, 1997). Inter-
estingly, the molecular basis for the ARF-dependent re-
cruitment of COPI and clathrin/AP-1 to two different
regions of the Golgi complex is not known. Clathrin/AP-2
vesicles mediate the internalization of proteins from the
plasma membrane, although recruitment of this coat does
not appear to require ARF. In addition, the recruitment of
COPII to ER membranes is mediated by the small GTP-
binding protein Sar1p rather than ARF.
In yeast
 
 Saccharomyces cerevisiae
 
, ARF is encoded by
two nearly identical genes, 
 
ARF1
 
 and 
 
ARF2
 
, that appear
to be functionally redundant. Deletion of both 
 
ARF
 
 genes
 
is lethal, but strains harboring either an 
 
arf1
 
D
 
 or an 
 
arf2
 
D
 
allele are viable and grow nearly as well as an isogenic
wild-type strain (Stearns et al., 1990a). However, deletion
of the more highly expressed 
 
ARF1
 
 gene causes a defect in
the kinetics of protein transport through the secretory
pathway, a reduction in Golgi-dependent glycosylation of
secreted glycoproteins, and substantial changes in the
morphology of Golgi cisternae and endosomes (Gaynor
et al., 1998; Stearns et al., 1990b).
To gain a better understanding of the essential role that
ARF plays in vivo, we have used a genetic screen to iden-
tify seven genes (
 
SWA1–SWA7
 
) for which mutant alleles
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exhibit synthetic lethality with 
 
arf1
 
D
 
. This genetic interac-
tion often predicts that the two gene products function in
the same pathway or in parallel pathways. 
 
swa5-1
 
 was pre-
viously identified as a new temperature-sensitive (ts) allele
of the clathrin heavy chain gene (
 
chc1-5
 
), providing sup-
port for a functional interaction in vivo between clathrin
and ARF (Chen and Graham, 1998)
 
.
 
 Deletion of the
 
CHC1
 
 gene can be lethal or viable depending on the strain
background. Mutants harboring 
 
chc1
 
D
 
, if viable, exhibit
slow growth, decreased rates of endocytosis, and a defect
in retention of late Golgi membrane proteins (Payne et al.,
1987, 1988; Payne and Schekman, 1989; Lemmon et al.,
1990). Disruption of the clathrin light chain gene (
 
CLC1
 
)
causes a reduced stability of Chc1p and results in pheno-
types similar to that of 
 
chc1
 
 mutants (Chu et al., 1996). Al-
though mutations in AP-1 subunits (Aps1p, Apm1p, and
Apl2p) do not result in any detectable phenotypes, a pair-
wise combination of 
 
aps1
 
D
 
, 
 
apm1
 
D
 
, or
 
 apl2
 
D
 
 with 
 
chc1-ts
 
exacerbates defects in growth and retention of Golgi resi-
dent proteins relative to the 
 
chc1-ts
 
 mutant (Phan et al.,
1994; Rad et al., 1995; Stepp et al., 1995).
Here we report that 
 
SWA3
 
 is allelic to 
 
DRS2
 
, which
 
 
 
en-
codes an integral membrane P-type ATPase (Ripmaster
et al., 1993) that is 47% identical to the mammalian ATP-
ase II purified from chromaffin granules (Tang et al.,
1996). ATPase II is thought to be an aminophospholipid
translocase (Auland et al., 1994; Zachowski et al., 1989),
capable of flipping phosphatidylserine (PS) or phosphati-
dylethanolamine (PE) from the external leaflet of a lipid
bilayer to the cytoplasmic leaflet to generate an asymmet-
ric distribution of these lipids in the two leaflets of a mem-
brane. In mammalian cells, most of the plasma membrane
PS is restricted to the cytoplasmic leaflet by the action of a
similar aminophospholipid translocase, but a calcium in-
flux induces the loss of plasma membrane lipid asymmetry
and results in the exposure of PS on the cell surface. This
event allows recognition and removal of apoptotic cells by
phagocytes, and in blood cells activates the coagulation
cascade (Williamson and Schlegel, 1994). Mammalian ATP-
ase II is found in chromaffin granules (Zachowski et al.,
1989), synaptic vesicles (Hicks and Parsons, 1992), and
clathrin-coated vesicles (Xie et al., 1989), although the
function of ATPase II in these vesicles is not known.
While there is no evidence that Drs2p generates phospho-
lipid asymmetry in the yeast plasma membrane, the 
 
drs2
 
D
 
mutant has been reported to exhibit a defect in transloca-
tion of a fluorescent PS derivative across the plasma mem-
brane (Tang et al., 1996). However, this result has been
disputed (Siegmund et al., 1998), calling into question
whether Drs2p functions as an aminophospholipid translo-
case at the plasma membrane.
In addition to the synthetic lethal interaction with 
 
arf1
 
D
 
,
we found that 
 
drs2
 
D
 
 also exhibits a specific synthetic lethal
interaction with 
 
chc1-ts
 
 alleles. Moreover, the 
 
drs2
 
D
 
 mu-
tant has a defect in late Golgi function and exhibits several
phenotypes at the nonpermissive temperature that suggest
a loss of clathrin function at the yeast Golgi in vivo. Con-
sistent with these observations, immunofluorescence and
subcellular fractionation studies indicate that Drs2p local-
izes to late Golgi membranes. These results argue that the
primary site of Drs2p function is in the Golgi complex
rather than the plasma membrane, and suggest a link be-
 
tween Drs2p and the ARF-dependent recruitment of
clathrin to Golgi membranes.
 
Materials and Methods
 
Strains and Media
 
Yeast cells were grown in standard rich medium (YPD), sporulation, or
SD minimal media containing required supplements and 0.2% yeast ex-
tract where indicated (Sherman, 1991). Strains used were SEY6210
(
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9
 
; Robin-
son et al., 1988), 6210 
 
drs2
 
D
 
 (SEY6210 
 
drs2
 
D
 
::TRP1), 6210 
 
arf1
 
D
 
(SEY6210 
 
arf1
 
D
 
::HIS3
 
; Gaynor et al., 1998), 6210 
 
chc1-ts 
 
(SEY6210 
 
chc1-
ts::URA3
 
; Chen and Graham, 1998), PRY6222 (
 
MATa leu2-3,112 ura3-52
his3-
 
D
 
200 
 
trp1-
 
D
 
901 ade 2-101 suc2-
 
D
 
9
 
 
 
drs2
 
D
 
::TRP1
 
), GPY1103 (
 
MATa
leu2-3,112 ura3-52 his4-519 trp1 can1 chc1-
 
D
 
8::LEU2; Payne et al., 1987),
EGY101-16D (
 
MATa leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 suc2-
 
D
 
9
 
ret1-1; Gaynor et al., 1998), LSY93.1-10A (
 
MAT
 
a
 
 
 
leu2-3,112 ura3-52 trp1
 
suc2 
 
clc1
 
D
 
::HIS3
 
; Chu et al., 1996), EGY1211-6B (
 
MATa leu2-3,112 ura3-
52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9 sec21-1
 
; Gaynor et al., 1998),
TBY103 (
 
MATa leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 sec23-1
 
),
TGY144 (
 
MAT
 
a
 
 leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 sec1-1
 
),
TGY1906 (
 
MATa leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 suc2-
 
D
 
9 pan1-
20
 
), TGY1912 (
 
MATa leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801
suc2-
 
D
 
9 end4-1
 
), SEY5185 (
 
MATa leu2-3,112 ura3-52 sec18-1
 
), BHY161
(SEY6210 
 
vps21
 
D
 
::HIS3
 
), BHY163 (SEY6210 
 
ypt7
 
D
 
::HIS3
 
), 6210 
 
vps33
 
D
 
(SEY6210 
 
vps33
 
D
 
::HIS3
 
), and 6210 
 
vps35
 
D
 
 (SEY6210 
 
vps35
 
D
 
::HIS3
 
).
 
Cloning of SWA3 and Plasmid Construction
 
To clone 
 
SWA3
 
, strain CCY2808 (
 
swa3-2
 
; Chen and Graham, 1998) was
transformed with a genomic library (Horazdovsky et al., 1994) and Leu
 
1
 
transformants were selected on synthetic dextrose-Leu media containing 4
 
m
 
g/ml adenine. After 7–10 d of incubation at 30
 
8
 
C, 50 colonies that ap-
peared to sector (out of 21,000 transformants) were streaked on 5
 
9
 
-fluoro-
orotic acid (FOA) plates. Library plasmids were rescued from the four
strains that grew on FOA and were retransformed into CCY2808. Only
the transformants harboring pPR10 were able to sector on YPD at 30
 
8
 
C
and were able to grow at 20
 
8
 
C. Partial sequencing indicated that the other
three plasmids contained 
 
ARF2
 
.
pPR10 contained a fragment of chromosome I from coordinates 94916–
104338. Deletion of the BamHI fragment contained solely in 
 
DRS2
 
 (to
produce pPR10
 
DBamHI) destroyed the complementing activity of
pPR10. The full-length DRS2 gene contained on a SpeI-SnaBI fragment
was subcloned into SpeI-SnaBI digested pRS315 or pRS425 to produce
pRS315-DRS2 and pRS425-DRS2. Both plasmids complemented the
cold-sensitive growth defect of CCY2808. A drs2 deletion plasmid
(pGCR1) was constructed by replacing a BamHI-SnaBI fragment in
pPR10 with an z1.1-kb BamHI-PvuII fragment containing TRP1 from
pJJ280 (Jones and Prakash, 1990). The plasmid pGCR1 was linearized
with SacI and HpaI and transformed into SEY6210 to produce 6210
drs2D. The correct integration event was confirmed by PCR.
Site-directed mutagenesis of DRS2 was performed by the megaprimer
PCR method (Barik and Galinski, 1991). To generate megaprimers
coding  for either a D to N or D to E mutation at amino acid position 560,
reverse primers TCCTGTCTTGTTACTGAATATAT and TCCTGTC-
TTTTCACTGAATATAT, respectively, were combined with forward
primer TTTGTCACCGTTGAATTAATC into a PCR reaction mixture
containing pRS315-DRS2. The gel purified z150-bp product was added to
a second PCR reaction containing the reverse primer TTCATCATC-
CAATCTTTCCAG and pRS315-DRS2. The resulting z650-bp products
were digested with BspEI and BglII, and then ligated into BspEI/BglII cut
pRS315-DRS2 to produce pDRS2(D560N) and pDRS2(D560E). Se-
quencing of the resulting plasmids indicated that the specific mutations
had been introduced with no additional mutations.
The 2-mm KEX2HA plasmid was constructed by subcloning a SalI/
EagI digestion fragment of pSN218 (Nothwehr et al., 1995), containing
the KEX2-HA sequence, into SalI/EagI-digested pRS426 to produce
p426KH. The HA.11 mouse monoclonal antibody (Covance) was used at
a 1:250 dilution to detect Kex2-HA by immunofluorescence.
Cell Labeling and Ste3p Turnover
Cell labeling, immunoprecipitation (Gaynor and Emr, 1997), FM4-64 up-Chen et al. Role for Drs2p in Late Golgi Function 1225
take (Vida and Emr, 1995), and Ste3p turnover (Davis et al., 1993) experi-
ments were performed as previously described. Ste3p-myc was detected
with 9E10 c-myc antibody (Oncogene Research Products) and HRP-con-
jugated secondary antibodies (Jackson ImmunoResearch Laboratories,
Inc.) followed by the enhanced chemiluminescence detection (Amersham
Corp.).
Subcellular Fractionation and Preparation of
Clathrin-coated Vesicles
Subcellular fractionation was performed as previously described (Phan
et al., 1994), except that cells were converted to spheroplasts and washed
twice in buffer containing 0.8 M sorbitol before lysing with a Dounce ho-
mogenizer in buffer A containing 0.1 mg/ml RNase A. The cells were pre-
incubated for 1 h at 158 or 308C, lysed, and subjected to centrifugation at
13,000 g and the resulting supernatant was then centrifuged at 100,000 g.
Immunoblots bearing 20 mg of protein from each sample were probed
with mouse antibodies to Chc1p (Lemmon et al., 1988), Aps1 and Aps2
(Phan et al., 1994), and ARF1 (Kahn et al., 1995). Clathrin-coated vesicles
(CCVs) were prepared from SEY6210 and 6210 drs2D as previously de-
scribed (Mueller and Branton, 1984). For 158C-treated samples, cells from
a 3-liter culture grown to 6–8 OD were collected, resuspended into 1 liter
of pre-chilled fresh YPD, and incubated at 158C for 1 h before further pro-
cessing. After gel filtration chromatography, 1.2 ml of every other fraction
(total 5 ml per fraction) from fractions 15–35 were precipitated with TCA
(10% final concentration). The precipitates were resuspended in 50 ml
Laemmli sample buffer, and one third of each sample was subjected to im-
munoblotting and probed with antibodies to Chc1p, Mnn1p (Graham et
al., 1994), and Pep12p (Seaman et al., 1998).
Electron Microscopy
Spheroplasts were prepared for electron microscopy as previously de-
scribed (Rieder et al., 1996) except that the initial glutaraldehyde fixation
was overnight at 48C. 50–60-nm sections were viewed on an electron mi-
croscope (CM12; Philips). Vesicle fractions were similarly prepared, but
included the following modifications: 5-ml fractions were fixed overnight
at 48C by addition of 700 ml of 25% glutaraldehyde (3% final concentra-
tion). Fixed vesicles were pelleted at 100,000 g for 70 min. The vesicle pel-
let was washed in 100 mM sodium cacodylate, pH 6.8, 5 mM CaCl2, and
then stained identically to the cell blocks, with one exception. A 30-min
room temperature incubation with 1% tannic acid in 100 mM sodium ca-
codylate, pH 7.4, was included before en bloc staining with uranyl acetate.
Dehydration, embedding, and section poststaining were performed as for
the cell samples.
Preparation of Antiserum Against Drs2p
A TrpE-DRS2 fusion construct was prepared by ligating the BglII/HindIII
cut DRS2 fragment (1,180 bp) from pPR10 into the BamHI/HindIII-
digested pATH2 vector (Koerner et al., 1991). The resulting plasmid con-
tained an in-frame fusion between TrpE and a region of Drs2p (amino ac-
ids 528–920) carrying ATPase motifs and predicted to be a cytoplasmic
loop. This plasmid was transformed into JM101 cells and the resulting fu-
sion protein was expressed and purified by the method of Koerner et al.
(1991), except that the procedure was scaled up 10-fold to increase yield.
Also, cracking buffer (10 mM sodium phosphate, pH 7.2, 1% b-mercapto-
ethanol, 1% SDS, 6 M urea) (Kleid et al., 1981) was used together with
sonication to resuspend the insoluble portion of the total cell lysate before
separation by preparative SDS-PAGE. The band from the preparative gel
corresponding to the TrpE/Drs2 fusion protein was cut out and electro-
eluted using an Elutrap (Schleicher & Schuell, Inc.). Polyclonal rabbit an-
tiserum to the Drs2-TrpE fusion protein was prepared at Scantibodies
Laboratory. Drs2p antibodies were affinity purified twice as described
(Pringle et al., 1991) using 500 mg of gel purified TrpE/Drs2 fusion protein
bound to an Immobilon (Millipore Corp.) strip by capillary action. Affin-
ity-purified anti–Drs2p antibody was used at a concentration of 1:1,000 for
immunofluorescence and 1:2,000 for Western blots. Cell lysates for West-
ern blots were prepared by vortexing cells with glass beads in SDS-urea
sample buffer (40 mM Tris-HCl, pH 6.8, 8 M urea, 0.1 mM EDTA, 1%
b-mercaptoethanol, 5% SDS) and heating at 508C for 5 min. Boiling of
samples caused aggregation of Drs2p such that the protein would remain
in the stacking gel during SDS-PAGE.
Results
drs2D Is Synthetically Lethal with arf1D and
chc1-ts Alleles
To clone the SWA3 gene, a yeast genomic library (CEN,
LEU2) was used to transform the swa3-1 mutant, and the
transformants were screened for complementation of the
cold-sensitive growth and arf1D synthetic lethal pheno-
types. A single library plasmid was isolated that was able
to complement both mutant phenotypes and further sub-
cloning analyses revealed that a 5-kb SpeI-SnaBI genomic
fragment containing the full-length DRS2 gene (and no
other open reading frame, ORF) retained the comple-
menting activity (see Materials and Methods).
A drs2 null strain was generated by replacing most of
the DRS2 coding sequences with TRP1. Consistent with
the phenotype previously reported for drs2D strains (Rip-
master et al., 1993) and that exhibited by the swa3 mutants
(Chen and Graham, 1998), the drs2D null mutant was un-
able to grow at 208C or below, but grew well at tempera-
tures above 238C. Linkage analysis indicated that SWA3 is
allelic to DRS2, and synthetic lethality between arf1D and
drs2D was confirmed by crossing the single mutants and
characterizing the progeny by tetrad analysis (Fig. 1 A
and data not shown). This genetic interaction suggested
that Drs2p may be involved in an ARF-dependent vesi-
cle-mediated protein transport event(s).
To determine if drs2D would exhibit synthetic lethality
with other mutations that perturb transport vesicle forma-
tion, we crossed drs2D with strains harboring ts mutations
in subunits of COPI (ret1-1, sec21-1, and sec27-1 encoding
a, g, b9-COP, respectively), the ER transport vesicle coat
Figure 1. drs2D is synthetically lethal with arf1D, chc1, and pan1
alleles. (A) Genetic analyses between drs2D and mutations that
perturb the secretory pathway. Strains carrying the indicated mu-
tations (see Materials and Methods) were crossed with a drs2D
mutant (6210 drs2D or PRY6222) to generate diploids. After tet-
rad analyses of the progeny, the viable double mutants were
streaked at 208, 26.58, and 378C to compare the growth relative to
parental strains carrying single mutations. *Double mutants of
the alleles and drs2 that were able to grow at 208C, where single
drs2 mutants could not. †Double mutants that grew more slowly
than either single mutant at 26.58C. (B) Tetrad analysis of prog-
eny derived from crossing PRY6222 (drs2D) with 6210 chc1-5
(chc1-5). Spores that failed to grow were predicted to be drs2D
chc1-5 double mutants.The Journal of Cell Biology, Volume 147, 1999 1226
COPII (sec12-1 and sec23-1), and the clathrin heavy chain
(chc1-5, chc1-D57, chc1-521), and analyzed the progeny by
tetrad dissection. All of the sec drs2D and the ret1 drs2D
double mutants were obtained at the expected frequency
(approximately one fourth of the progeny) and most grew
well at 26.58C (Fig. 1 A). The exception was sec21-1 drs2D
mutants, which grew somewhat more slowly at this tem-
perature than either single mutant. Among those growing
well at 26.58C, double mutants harboring drs2D and sec12-1
or sec23-1 also grew at 208C, which is a nonpermissive tem-
perature for drs2D single mutants. This suggests that sec12
and sec23 are able to partially suppress the cold-sensitive
growth defect of drs2D, and that COPII may act upstream
of Drs2p.
In stark contrast, chc1-ts drs2D double mutants were
nearly always inviable. All of the spores that failed to grow
in the tetrad analysis shown in Fig. 1 B were predicted to
be chc1-5 drs2D double mutants based on the genotype of
the viable spores from each tetrad. The drs2D and chc1-5
single mutants grew nearly as well as wild-type progeny
at this temperature (26.58C, Fig. 1 B; e.g., spores 3c, 3d,
and 3b are drs2D, chc1-5, and wild-type, respectively). Mi-
croscopic examination of the plates indicated that the
drs2D chc1-5 spores germinated and divided a few times
to form microcolonies, indicating that mitotic growth,
rather than germination, was impaired. In addition, this
genetic interaction was not allele-specific since all three of
the  chc1  ts alleles tested were synthetically lethal with
drs2D (Fig. 1 A).
To further address the specificity of the synthetic lethal
interaction between drs2D, arf1D, and chc1-ts alleles, we
crossed drs2D with several mutants that exhibit a defect in
protein transport through the secretory or endocytic path-
ways. Double mutants combining drs2D with sec1-1, sec7-1,
sec14-1, sec18-1, vps15D, vps21D, vps33D, vps35D, ypt7D,
or  end4-1  were obtained at the expected frequency, al-
though the end4-1 drs2D, vps33D drs2D, and sec18-1 drs2D
mutants exhibited a slow growth phenotype. Interestingly,
a mutant allele of the yeast Eps15 homologue, pan1-20,
was also synthetically lethal with drs2D (Fig. 1 A). Eps15 is
a cytoplasmic protein that localizes to clathrin-coated pits
and may have an adaptor-like function in clathrin coated
vesicle formation (van Delft et al., 1997; Wendland and
Emr, 1998). Of particular note was the lack of genetic in-
teractions with sec7 and sec14, which both perturb protein
transport through the yeast Golgi complex.
The drs2D Mutant Secretes Pro–a-Factor at the 
Nonpermissive Temperature
One of the more striking phenotypes of yeast clathrin mu-
tants is the mislocalization of several late Golgi (TGN)
proteins that are required for pro–a-factor proteolytic
processing. This results in the secretion of fully glycosy-
lated pro–a-factor rather than the mature peptide (Payne
and Schekman, 1989). If clathrin function at the TGN is
perturbed in the drs2D mutant, we would expect this mu-
tant to secrete pro–a-factor. To test this, wild-type, drs2D,
and clc1D (clathrin light chain null) strains were grown at
308C, and after shifting to 208C for 1 h, were metabolically
labeled and chased at this nonpermissive temperature for
drs2D. Aliquots of cells were removed at the chase times
indicated in Fig. 2, converted to spheroplasts, and then
centrifuged to separate intracellular (I) from extracellular
(E) fractions. a-Factor was then recovered from each sam-
ple by immunoprecipitation.
At the beginning of the chase, labeled a-factor was
present throughout the secretory pathway of the cells, as
indicated by the presence of the core glycosylated ER pro-
form, Golgi-modified hyperglycosylated proforms and the
mature form (Fig. 2, lanes 1, 7, and 13). In wild-type cells,
complete proteolytic processing of pro–a-factor occurred
within 15 min, and most of the mature a-factor was se-
creted and degraded in the extracellular space. However,
the clc1D cells were clearly deficient in the processing of
pro–a-factor, and most of the hyperglycosylated precursor
was secreted into the extracellular space within 15 min, as
previously reported (Fig. 2, lane 18; Chu et al., 1996). Sim-
ilarly, the drs2D mutant secreted the hyperglycosylated
pro–a-factor and partially processed a-factor forms into
the extracellular space (Fig. 2, lanes 10 and 12). The drs2D
mutant also exhibited a modest defect in Golgi-specific
glycosylation since the hyperglycosylated pro–a-factor se-
creted from drs2D cells showed a slightly faster mobility
within the SDS-polyacrylamide gel relative to that from
the clc1D strains. The kinetics of pro–a-factor secretion at
this temperature (208C) was nearly equivalent to that of
clc1D cells. These results indicate that late Golgi function
is specifically perturbed in the drs2D cells and suggest a
loss of clathrin function at the TGN at the nonpermissive
temperature. In pulse–chase experiments performed at
308C, most of pro–a-factor was processed and secreted as
the mature form from drs2D cells (data not shown), indi-
cating that this defect was temperature conditional. More-
over, the pro–a-factor processing defect was observed
within 15 min of preincubation at 208C, suggesting a rapid
onset of the temperature conditional phenotype (data not
shown).
Figure 2. The drs2D mutant exhibits a cold-sensitive defect in
pro–a-factor processing. Wild-type, drs2D (hereafter used to rep-
resent SEY6210 and the isogenic strain 6210 drs2D, respectively),
and clc1D (LSY93.1-10A) strains were labeled for 10 min at 158C,
chased for the times indicated, and converted to spheroplasts. In-
tracellular (I) and extracellular (E) portions were separated by
centrifugation and subjected to immunoprecipitation with antise-
rum to a-factor.Chen et al. Role for Drs2p in Late Golgi Function 1227
The drs2D Mutant Exhibits an Endosomal Defect
To examine protein transport through the endocytic path-
way of drs2D cells, we followed the turnover of the a-fac-
tor receptor, Ste3p, which is constitutively endocytosed
and delivered to the yeast vacuole where it is degraded
(Davis et al., 1993). A c-myc tagged Ste3p expressed from
a galactose-regulated promoter (Davis et al., 1993) was
used so new Ste3p synthesis can be shut off by shifting the
cells to glucose. Wild-type, drs2D, and arf1D cells were
grown in galactose at 308C to induce expression of the con-
struct and populate the plasma membrane with the Ste3-
myc protein. Glucose was added to the culture, which was
then shifted to 158C, and the disappearance of Ste3-myc
was followed over time by immunoblotting. Even though
the arf1D mutant displays an abnormal endosome mor-
phology (Gaynor et al., 1998), the kinetics of Ste3p trans-
port to the vacuole as measured by Ste3-myc degradation
was very similar to that of wild-type cells (Fig. 3 A, arf1D).
In contrast, the rate of Ste3-myc turnover was three- to
fivefold slower in the drs2D cells (Fig. 3 A, drs2D) com-
pared with wild type, suggesting a defect in endocytosis.
To control for recovery of protein in each sample, the
same blots were probed for carboxypeptidase Y (CPY),
which was recovered equally in each sample (data not
shown). drs2D cells cultured in glucose did not express
Ste3p-myc, indicating that glucose repression of the GAL
promoter was not perturbed (data not shown). Again, this
phenotype was temperature conditional since the rate of
Ste3-myc turnover at 308C in the drs2D strain was only
slightly (1.4-fold) slower than the wild-type strain (data
not shown).
Clathrin mutants display a similar defect in Ste3p turn-
over caused by inefficient internalization of the receptor
from the plasma membrane (Tan et al., 1993). However,
examination of drs2D cells by immunofluorescence local-
ization of Ste3p-myc at each time point after glucose was
added indicated an accumulation of Ste3-myc in intracel-
lular structures with very little plasma membrane staining
(data not shown). This result suggested that transport of
Ste3p from the endosome to the vacuole, rather than inter-
nalization from the plasma membrane, was perturbed.
To more specifically test whether uptake from the
plasma membrane or transport from endosomes to the
vacuole was defective in drs2D cells at the nonpermissive
temperature, we stained cells with the fluorescent en-
docytic marker FM4-64 (Vida and Emr, 1995) on ice, and
then shifted the cultures to 158C to initiate endocytosis of
the dye (Fig. 3 B). The FM4-64 was rapidly cleared from
the plasma membrane of both wild-type and drs2D cells
(data not shown), and in wild-type cells it was delivered to
the vacuole membrane in 30–60 min (WT, 1 h). In con-
trast, the FM4-64 accumulated in endosomes of drs2D
cells, which appear as punctate fluorescent spots in Fig. 3
B (drs2D, 1 h). Even after 4 h at 158C, most of the FM4-64
was not in the vacuoles and stained what appeared to be
clusters of smaller structures (drs2D, 4 h). As the drs2D
cells warmed up on the microscope stage, the FM4-64 was
rapidly delivered to the vacuoles at all times tested, in-
dicating that the defect was fully reversible (data not
shown). In addition, vacuoles in drs2D cells that were
stained with FM4-64 at 308C did not appreciably fragment
when the cells were shifted to 158C (data not shown), so
the structures stained at 158C were indeed endosomes and
not fragmented vacuoles.
These studies indicated that the endocytic defect ob-
served in drs2D cells was attributable to a defect in the en-
dosome-to-vacuole pathway rather than clathrin-depen-
dent endocytosis from the plasma membrane. If so, CPY
transport should be affected as well since this protein fol-
lows a TGN to endosome to vacuole delivery route. To
test this, we examined the transport of CPY to the vacuole
in the drs2D mutant. CPY is synthesized in the ER as the
p1 precursor form and is modified on N-linked oligosac-
charides by the Golgi a1,3 mannosyltransferase (Mnn1p)
to form the p2 precursor. p2 CPY is sorted from secreted
proteins in the TGN and ultimately processed to the ma-
ture form in the vacuole (Stevens et al., 1982). Wild-type,
drs2D, and arf1D cells were pulse-labeled and chased at
either the permissive or nonpermissive temperature of
drs2D. Aliquots of cells were removed at the chase times
indicated and CPY was recovered by immunoprecipita-
tion. As shown in Fig. 4, drs2D cells displayed near wild-
Figure 3. The drs2D mutant exhibits a cold-sensitive defect in the
endocytic pathway. (A) Wild-type, drs2D, and arf1D strains were
transformed with a plasmid carrying the Ste3-myc  construct
(pSL2624; Givan and Sprague, 1997) and grown to early log
phase in galactose to induce expression of the STE3-myc protein.
Glucose was added to 3% final concentration to repress new syn-
thesis of Ste3-myc and the cultures were shifted to 158C. Lysates
were prepared at the times indicated and immunoblotted for
Ste3-myc using the 9E10 c-myc antibody. (B) Wild-type and
drs2D cells were stained with FM4-64 on ice and shifted to 158C
to initiate endocytosis of the dye. Images were captured at 1 and
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type CPY transport kinetics at 308C, while at 158C the
transport of CPY in drs2D mutants was significantly de-
layed relative to that in the wild-type cells, and was similar
to the defect observed in arf1D cells at either temperature
(approximately threefold slower transport kinetics). The
partial glycosylation defect observed in drs2D (and arf1D
cells) prevented the formation of a p2 CPY form that
could be resolved from the p1 form in SDS-polyacryl-
amide gels. Thus, the kinetics of ER-to-Golgi transport
could not be assessed for CPY. However, the ER-to-Golgi
transport kinetics for a-factor and invertase in drs2D cells
was found to be nearly wild type at the nonpermissive
temperature, as scored by disappearance of the ER core
form (Fig. 2, and data not shown). Therefore, it is unlikely
that ER-to-Golgi transport for CPY is disturbed in drs2D
cells. These data are most consistent with the interpreta-
tion that protein transport from the late Golgi or endo-
somes to the vacuole is perturbed by the drs2D mutation.
Interestingly, the chc1-5 allele isolated in the arf1D syn-
thetic lethal screen also exhibits a partial glycosylation de-
fect and an approximately threefold slower transport ki-
netics for CPY (Chen and Graham, 1998).
The drs2D Mutant Accumulates Abnormal
Membrane-bound Structures Similar to Berkeley Bodies
Most of the sec mutants that exhibit a temperature-condi-
tional block in protein transport also accumulate an or-
ganelle or vesicular intermediate of the secretory pathway
at the nonpermissive temperature. For example, the sec7
Figure 4. The drs2D mutant exhibits a cold-sensitive kinetic de-
fect in CPY transport to the vacuole. Wild-type, drs2D, and arf1D
(all isogenic to SEY6210) strains were labeled for 10 min at 158 or
308C, and then chased for the times indicated. CPY was recov-
ered from each sample by immunoprecipitation and subjected to
SDS-PAGE.
Figure 5. The drs2D mutant accumulates abnormal membrane structures that are similar to Berkeley bodies. Electron micrographs of
drs2D cells incubated for 2 h at 158C (A) or kept at 308C (B) showing numerous double-membrane ring and crescent-shaped structures.
Plasma membrane (PM) and vacuoles (V) are labeled. The black arrowhead in A denotes a modestly fenestrated ring structure. The ar-
rowhead in B shows a ring structure with a stacked crescent membrane. For comparison, an electron micrograph of similar structures
observed in a chc1D cell (C, GPY1103) is shown. Narrower, more fenestrated, and typically incomplete ring structures were also found
in wild-type (WT) cells grown at 308C (D, arrowhead). These wild-type ring structures did not stain as darkly as rings found in the drs2D
mutant (compare to double arrowhead in A). Bars, 0.2 mm. E, drs2D and wild-type cells grown at the indicated temperatures were visu-
alized by transmission electron microscopy. Membrane bound structures from 23–25 randomly selected cells were counted and ex-
pressed as an average number of structures per cell section.Chen et al. Role for Drs2p in Late Golgi Function 1229
and  sec14  mutations block protein transport out of the
Golgi complex and accumulate Golgi structures called
Berkeley bodies (Novick et al., 1980). The Golgi cisternae
in these mutants are sometimes stacked and appear to
adopt a deep, cup-shaped morphology that in electron mi-
crographs of thin sections present double-membrane ring
or crescent shaped structures depending on the section
plane. Clathrin mutants also exhibit aberrant membrane
structures similar to Berkeley bodies, although these struc-
tures are rarely stacked (Payne et al., 1987).
Morphological studies by electron microscopy revealed
that drs2D cells accumulated aberrant double-membrane
ring and crescent-shaped structures at both 158 and 308C
(Fig. 5, A and B). The double-membrane rings in the
drs2D cells measured 200–250 nm in diameter (average,
240 nm) and often presented a significant gap between the
concentric membranes, which should be equivalent to the
luminal space of the cisternae. Representative double-
membrane ring structures are marked with white arrow-
heads in Fig. 5 A. Very similar ring structures also accu-
mulated in the chc1D mutant (Fig. 5 C; Payne et al., 1987).
These types of structures were never observed in wild-type
cells; however, ring structures could be found that were
more highly fenestrated and appeared to be breaking
down into tubules or vesicles (Fig. 5 D, arrowhead). In
fact, similar fenestrated ring structures accumulate dra-
matically in arf1D cells (Gaynor et al., 1998). Some of the
double-membrane rings in the drs2D cells were also mod-
estly fenestrated (Fig. 5 A, black arrow).
To quantitate the effect of temperature on the accumu-
lation of ring structures in wild-type and drs2D cells, these
cells were grown at 26.58C and shifted to the temperature
indicated in Fig. 5 E for 2 h before fixation. Regions con-
taining 23–25 cell sections were randomly selected and the
number of crescent-shaped structures, double-membrane
rings, and vesicles (50–100-nm spheres) were counted and
expressed as the number of structures per cell section. Rel-
ative to the wild-type strain, the drs2D mutant accumu-
lated four- to eightfold more crescent and ring structures
at the temperatures examined (Fig. 5 E). In this analysis,
structures similar to that shown in Fig. 5 D were counted
as rings in the wild-type cells. There was also a greater ac-
cumulation of these structures in the drs2D cells at the
colder temperatures, which was particularly evident for
the double-membrane rings. The number of vesicles in the
drs2D cells dropped modestly at the colder temperatures,
although within the range of values observed for the wild-
type cells.
Golgi membranes that accumulate at the nonpermissive
temperature in the sec7 mutant have been reported to be-
come more extensively stacked in low glucose medium
(Novick et al., 1980). Some structures appear stacked in
the drs2D mutant grown in 2% glucose (Fig. 5 B, arrow),
but no significant difference was observed in the morphol-
ogy of the membranes accumulating in drs2D cells incu-
bated in low glucose (0.1%) medium for 2 h at the nonper-
missive temperature. However, the effect of low glucose
on Berkeley body structure in a sec7 mutant in our strain
background was modest (data not shown).
Plasma membrane invaginations have been proposed to
represent endocytic intermediates in yeast (Mulholland
et al., 1999) and are extended in some mutants that exhibit
a defect in endocytosis [for example, sjl1 sjl2 (Srinivasan
et al., 1997) and pan1 (Wendland et al., 1996)]. However,
no difference in the depth of plasma membrane invagina-
tions between wild-type and drs2D cells was observed un-
der any of the growth conditions described above.
Reduction of Intact Clathrin-coated Vesicles that Can 
Be Isolated from the drs2D Mutant
A mammalian cytosolic ARF guanine nucleotide ex-
change factor requires both PS and phosphatidylinositol-
4,5-bisphosphate for optimal membrane binding and sub-
sequent activation of ARF (Chardin et al., 1996). This
observation suggested a requirement for Drs2p (a poten-
tial PS translocase) to recruit ARF and clathrin to mem-
branes. To test whether Drs2p plays a role in regulating
ARF activation and therefore association of ARF and
clathrin with membranes, we fractionated both wild-type
and drs2D cellular lysates by differential centrifugation to
compare the amounts of ARF, clathrin, and adaptin sub-
units recovered in the 13,000-g pellets, and the 100,000-g
pellets and supernatants. A small increase in the amount
of clathrin heavy chain found in the 100,000-g supernatant
fraction was occasionally observed in the mutant samples
relative to the wild-type samples at both 158 and 308C; oth-
erwise, the fractionation pattern for clathrin was very simi-
lar between the two strains (data not shown). In addition,
the fractionation pattern for ARF and the two adaptin
small subunits (Aps1p for AP-1 and Aps2p for AP-2) was
nearly identical between drs2D and wild-type samples.
Therefore, the association of ARF and clathrin with bulk
cellular membranes seemed to be unaffected in the drs2D
mutant, although we cannot rule out the possibility that
the distribution of ARF between specific organelles is per-
turbed.
To further assess clathrin function in the drs2D mutants,
we asked whether CCVs could be purified from this mu-
tant. CCV preparations were generated from drs2D and
wild-type cells with or without a 1-h shift to 158C (see Ma-
terials and Methods). Cell lysates were centrifuged at
21,000  g for 30 min to pellet large organellar membranes
(e.g., plasma membrane, vacuolar membrane, ER, and mi-
tochondria) and the resulting supernatant was centrifuged
at 100,000 g to pellet vesicles. The 100,000-g pellet was
then applied to a Sephacryl S-1000 gel filtration column
(Mueller and Branton, 1984), and the fractions were
probed for the clathrin heavy chain by immunoblotting.
As shown in Fig. 6 A, the clathrin heavy chain was highly
enriched in fractions 23 to 27 for both wild-type and drs2D
samples from cells shifted to 158C (Fig. 6 A) or 308C (Fig.
7 D, and data not shown). In addition, from Coomassie
blue–stained gels, we estimated that the recovery of clath-
rin heavy chain in these fractions was comparable for both
strains at both temperatures (data not shown).
However, a clear difference between wild-type and mu-
tant samples was evident when fractions highly enriched
for the clathrin heavy chain were examined by EM. Peak
clathrin fractions obtained from wild-type cells were sub-
stantially enriched in CCVs with a clear lipid bilayer
present in a substantial number of the vesicle profiles (Fig.
6 C, arrowheads). In contrast, most of the vesicle profiles
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dense center, but no lipid bilayer within the clathrin basket
(Fig. 6 D, open arrowheads). In addition, the drs2D frac-
tions contained what appeared to be partially assembled
clathrin lattices (Fig. 6 D, arrow) that were rarely ob-
served in wild-type fractions. CCVs with a lipid bilayer
were occasionally observed in the drs2D fractions, but
were found at ,1/10 of the frequency per section as com-
pared with the wild-type samples (multiple sections from
three different preparations were compared). This was a
temperature-conditional phenomenon as CCV prepara-
tions from drs2D cells maintained at a permissive tempera-
ture were indistinguishable from wild-type samples (data
not shown).
It is well established that clathrin triskelions can self as-
semble into baskets in slightly acidic, low ionic strength
buffers (Schmid, 1997, and references therein). The
method we used for isolating CCVs from yeast applies
such buffer conditions to retain assembled coats on vesi-
cles. In addition, the lysate is incubated for 30 min at 308C
with RNase to reduce the amount of ribonucleoprotein
complexes in the P100 sample. These conditions are likely
to induce assembly of free clathrin triskelions into baskets
and lattices within the drs2D cell lysate. It appears that
these clathrin structures pellet at 100,000 g and elute from
the S-1000 column in similar fractions as bona fide CCVs.
The simplest interpretation of these data is that the drs2D
cells are deficient in producing CCVs at the nonpermissive
temperature. It is also possible that clathrin dissociates
more readily from CCVs produced in drs2D cells and reas-
sembles into baskets during purification, thus preventing
the isolation of bona fide CCVs. In either case, there is a
marked difference between drs2D and wild-type cells ei-
ther in the ability to produce CCVs or in the physical
properties of CCVs from these strains.
Even though most large membranes pellet at 21,000 g,
we had noticed by EM that the 100,000-g pellet from drs2D
cells (that was applied to the S1000 column) contained a
significant number of aberrant membrane structures that
were similar in appearance and size to those observed in
cell sections (Fig. 5 B). Because drs2D cells exhibited both
Golgi and endosome-associated defects, it was possible
that both organelles would accumulate in the drs2D mu-
tant. Therefore, we examined the S1000 column fractions
from the CCV preparations for membranes containing a
late Golgi protein, a1,3-mannosyltransferase (Mnn1p),
and an endosomal t-SNARE, Pep12p (Fig. 6 A). In frac-
tions from wild-type cells, Mnn1p eluted slightly later than
clathrin, which likely represents small vesicles or small
Golgi fragments. However, a substantial change in the elu-
tion profile of Mnn1p-containing membranes was ob-
served in fractions from drs2D cells. A peak of Mnn1p
eluted just after the void volume and spread from fractions
16–31. This change in Mnn1p distribution was observed
with samples prepared from drs2D cells incubated at both
158C (Fig. 6 A) and 308C (data not shown), and correlated
with the large membrane structures observed by EM in
these fractions (e.g., Fig. 6 B, fraction 16). Membranes of
any sort were difficult to find by EM in fraction 16 from
wild-type samples (data not shown). Relative to Mnn1p, a
wider distribution of Pep12p-containing membranes was
found in the S1000 fractions from wild-type cells.
However, the Pep12p elution profile was not significantly
Figure 6. The drs2D mutant ac-
cumulates aberrant Golgi mem-
branes and exhibits a deficiency
of clathrin-coated vesicles. (A)
Wild-type and drs2D cells were
grown at 308C and shifted to
158C for 1 h, and then lysed and
subjected to centrifugation at
21,000  g for 30 min. The 21,000-g
supernatant was centrifuged at
100,000  g for 80 min to generate
a 100,000-g pellet. This pellet
was resuspended and further re-
solved on a Sephacryl S-1000
column. Samples of every other
fraction from fraction 15 to 35
were assayed by immunoblotting
for the clathrin heavy chain
(Chc1p), a late Golgi protein
Mnn1p, and an endosomal
t-SNARE Pep12p. (B–D) Mem-
branes in fraction 16 from the
drs2D sample where Mnn1p was
found (B), and fraction 26 from
wild-type (C) and drs2D (D)
samples where Chc1p was en-
riched were fixed, pelleted, and
examined by EM. Bars, 50 nm.Chen et al. Role for Drs2p in Late Golgi Function 1231
different between the wild-type and drs2D fractions (Fig.
6 A). These data suggest that the abnormal membrane
structures that accumulate in the drs2D cells are Golgi
membranes and not endosomal membranes.
Drs2p Localizes to Late Golgi Membranes Containing 
Kex2p and Mnn1p
To analyze the intracellular localization of Drs2p, we pre-
pared a rabbit polyclonal antiserum against a bacterially
expressed fragment of Drs2p (amino acid residues 528–
920). Affinity-purified anti–Drs2p antibodies recognized
an z150-kD protein on an immunoblot of a wild-type cell
lysate (Fig. 7 A, DRS2), which is in close agreement to the
predicted mass of 154 kD. This protein was not present in
a drs2D cell lysate and was found in greater abundance in
wild-type strain carrying DRS2 on a multicopy plasmid
(Fig. 7 A, drs2D and 2 m DRS2). Thus, the 150-kD protein
is equivalent to Drs2p.
Drs2p was recently suggested to localize to the plasma
membrane based on cofractionation of an epitope-tagged
Drs2p with the plasma membrane ATPase, Pma1p, in su-
crose gradient fractions from a crude cell lysate (Siegmund
et al., 1998). However, we found that membranes contain-
ing Drs2p could be quantitatively separated from mem-
branes containing Pma1p by differential centrifugation
as described above for the CCV preparations. Equal
amounts of protein from the lysate (L), pellet (P21), and
supernatant (S21) of 21,000 g and pellet (P100) and super-
natant (S100) of 100,000 g were probed for Drs2p and
Pma1p. Nearly all of Drs2p remained in the supernatant
after centrifuging at 21,000 g (S21) while most of Pma1p
was found in the pellet (P21) (Fig. 7 B). All of the Drs2p in
the S21 was pelleted during the subsequent 100,000-g cen-
trifugation step and was found in the P100 fraction.
The fractionation profile for Drs2p shown in Fig. 7 B is
very similar to how CCV and late Golgi proteins such as
Kex2p fractionate. To further characterize the localization
of Drs2p, a P100 fraction was applied to the bottom of a
sucrose gradient and centrifuged to equilibrium (Reynolds
et al., 1998). Fractions were collected from the top and
probed for Drs2p and Mnn1p and assayed for GDPase
and Kex2p (Fig. 7 C). GDPase marks early Golgi compart-
ments, Kex2p the late Golgi (or TGN), and Mnn1p is typi-
cally split between these two regions of the gradient. The
fractionation pattern for Drs2p clearly matches that of
Kex2p (Fig. 7 C). In similar gradients, we found that
the endosomal marker Pep12p was broadly distributed
throughout the gradient (data not shown), although others
have observed a defined peak in fractions significantly
lighter than that of Kex2p (Becherer et al., 1996). In no
case did the Pep12p fractionation pattern match with that
of Drs2p. In addition, the S1000 column elution profile of
membranes containing Drs2p (from wild-type cells grown
at 308C) matched that of membranes containing Mnn1p
(Fig. 7 D). The Drs2p elution profile overlapped that of
CCVs (Fig. 7 D), raising the possibility that some Drs2p is
present within the CCVs. This possibility is currently being
tested; however, it appeared that the bulk of Drs2p resides
in Golgi membranes.
To determine whether Drs2p and Kex2p reside in the
same membrane structures, wild-type cells overexpressing
a hemagglutinin (HA)-tagged Kex2p were stained simul-
taneously with antibodies to Drs2p and HA. Localization
of Drs2p by immunofluorescence produced a punctate
staining pattern that is typical for the yeast Golgi complex
(Fig. 8, WT 1 2m KEX2HA, a-Drs2p). Although the sig-
Figure 7. Drs2p cofractionates with high-density membranes
containing the late Golgi markers, Kex2p and Mnn1p. (A) Speci-
ficity of the Drs2p antibodies. Wild-type, drs2D, and SEY6210
pRS425-DRS2 (2m DRS2) cells were grown at 308C before lysing
with glass beads in SDS-urea sample buffer. Total cellular pro-
teins (0.1 OD per lane) were subjected to SDS-PAGE and immu-
noblotted with affinity-purified antibodies against Drs2p. (B)
Wild-type cells grown at 308C were lysed (lysate, L) and sub-
jected to centrifugation at 21,000 g for 30 min to generate pellet
(P21) and supernatant (S21) fractions. The S21 fraction was fur-
ther centrifuged at 100,000 g for 80 min to generate pellet (P100)
and supernatant (S100) fractions. 20 mg of total protein per frac-
tion was immunoblotted for Drs2p and the plasma membrane
ATPase, Pma1p. (C) Wild-type cells grown at 308C were lysed
and subjected to differential centrifugation and sucrose gradient
fractionation of the P100 fraction. These gradient fractions have
been previously used to examine Mnn1p distribution in Figure 6
a of Reynolds et al. (1998). Equal volumes per gradient fraction
were assayed by enzyme activity for Kex2p or GDPase and by
immunoblotting for Drs2p, Mnn1p, and Pep12p. (D) Wild-type
cells were grown at 308C, lysed, and subjected to differential cen-
trifugation to produce a P100 fraction, which was then subjected
to gel filtration chromatography as described in Fig. 6. Samples
of every other fraction from fraction 15 to 35 were assayed by im-
munoblotting for the clathrin heavy chain (Chc1p), the late Golgi
protein Mnn1p and Drs2p.The Journal of Cell Biology, Volume 147, 1999 1232
nal was weak, it was clearly above the background staining
observed for the drs2D strain (Fig. 8, drs2D). The HA anti-
body also produced a punctate staining pattern (Fig. 8,
WT  1 2m KEX2HA, a-HA) and, importantly, most of the
structures that were positive for Drs2p also stained for
Kex2-HA. As expected, very little overlap was observed
between Drs2p and the early Golgi marker Och1-HA
(data not shown).
We could not detect plasma membrane staining with the
Drs2p antibodies, which is inconsistent with a previous re-
port suggesting that Drs2p resides in the plasma mem-
brane (Siegmund et al., 1998). Overexpression of Drs2p
from a multicopy plasmid resulted in an ER staining pat-
tern (Siegmund et al., 1998, and data not shown), so this
method could not be used to enhance the signal. To deter-
mine whether the lack of plasma membrane staining with
Drs2p antibodies was due to a technical limitation, we
tested whether we could detect plasma membrane staining
for an antigen that is present in the Golgi, endosomes, and
plasma membrane. Wild-type spheroplasts were stained
with antibodies to a1,3-linked mannose residues that are
found on many glycoproteins. For these cells, staining of
the plasma membrane is clearly observed as a stained rim
around the cells (Fig. 8, anti–a1,3). Thus, by both immu-
nofluorescence and subcellular fractionation studies, it ap-
pears that most, if not all, of Drs2p is found in late Golgi
membranes.
Mutation of Aspartic Acid 560 Abolishes Drs2p 
Function In Vivo
Drs2p is predicted to be a P-type ATPase based on the
presence of five well-conserved ATPase motifs involved in
the binding and hydrolysis of ATP (Fig. 9 A). For P-type
ATPases, an aspartic acid within the second motif forms
an aspartyl-phosphate catalytic intermediate that is essen-
tial for ATP hydrolysis (Allen and Green, 1976; Fagan and
Saier, 1994). Sequence alignments between Drs2p and
other P-type ATPases predict that aspartic acid 560
(D560) in Drs2p would form the aspartyl-phosphate inter-
mediate (Fig. 9 A). To test whether this amino acid is criti-
cal for Drs2p function, we mutated D560 to either an as-
paragine (D560N) or a glutamic acid (D560E) residue and
examined the ability of the mutants to complement the
cold-sensitive growth defect of the drs2D strain. These mu-
tations would be expected to cause minimal structural Figure 8. Drs2p colocalizes with Kex2p in internal, punctate
membranes. The wild-type strain carrying the HA-tagged KEX2
on a 2-mm plasmid (WT 1 2m KEX2HA), and the drs2D strain
were grown overnight at 308C in minimal medium. After dilution
in rich medium to 0.2 OD600, the wild-type strain was shifted to
208C and cultured for 7 h while the drs2D strain was cultured at
308C for 5 h, and then shifted to 208C for 2 h. Cells were then
fixed and prepared for immunofluorescence as previously de-
scribed (Graham et al., 1994). Affinity-purified anti–Drs2p and
monoclonal anti–HA antibodies were used in the top six panels
to visualize Drs2p (left) and the HA-tagged Kex2p (right) in the
same cells. The bottom two panels are DIC and immunofluores-
cence images of wild-type cells grown at 208C and labeled with an
antibody specific for a1,3-linked mannose. Notice how the punc-
tate and rim staining pattern (plasma membrane) of a1,3-man-
nose epitopes is different from the punctate staining of Drs2p in
wild-type cells.
Figure 9. Mutation of a conserved ATPase motif causes loss of
Drs2p function in vivo. (A) Comparison of five conserved con-
sensus motifs of yeast P-type ATPases and the corresponding se-
quence in Drs2p (adapted from Catty et al., 1997). The arrow in-
dicates the aspartic acid residue (D) at position 560, which was
mutated to glutamic acid (E) or asparagine (N). (B) The drs2D
strain containing plasmids pDRS2(D560E), pDRS2(D560N),
pRS315-DRS2 (wild-type), and the pRS315 empty vector (drs2D)
were grown at 308 or 208C for 3 d.Chen et al. Role for Drs2p in Late Golgi Function 1233
changes in Drs2p, but should abolish the presumed ATP-
ase activity of this protein. The drs2D strain carrying either
the wild-type DRS2 gene (Wild-type), an empty vector
(drs2D), or two independent isolates of each mutant
(D560N and D560E) were tested for growth at 308 and
208C (Fig. 9 B). As previously reported, the drs2D strain
failed to grow at 208C, but grew well at 308C. None of the
strains carrying the D560 point mutations were able to
grow at 208C (Fig. 9 B), even though each of the strains ex-
pressed a wild-type level of Drs2p (data not shown). These
data support the assignment of Drs2p as a P-type ATPase
and suggest that the ATPase activity of Drs2p is essential
for its function in vivo.
Discussion
In this report, we present several lines of evidence that
strongly implicate the integral membrane P-type ATPase
Drs2p in late Golgi function, and suggest a link between
Drs2p and CCV formation from Golgi membranes. (a) A
specific synthetic lethal interaction was found between
drs2D, arf1D, and chc1-ts alleles. (b) The drs2D mutant ex-
hibits a cold-sensitive defect in the proteolytic processing
of pro–a-factor in the yeast TGN that is comparable with
the defect shown by clathrin mutants. (c) The drs2D mu-
tant accumulates aberrant Golgi structures that are mor-
phologically comparable to the membrane structures that
accumulate in clathrin mutants. (d) We observed a sub-
stantial decrease in the yield of CCVs that could be iso-
lated from the drs2D mutant preincubated at the nonper-
missive temperature. (e) Drs2p localizes to late Golgi
membranes containing Kex2p.
Specific Genetic Interactions between drs2D, arf1D, and 
chc1-ts Alleles
Our rationale for performing the arf1D synthetic lethal
screen was that it could provide an unbiased, in vivo ap-
proach to identify proteins that regulate ARF function, or
participate with ARF in CCV or COPI vesicle formation.
This was the first yeast genetic screen we are aware of that
has uncovered a mutant allele of the clathrin heavy chain
gene (swa5-1/chc1-5; Chen and Graham, 1998). While mu-
tations at many loci can influence the viability of a chc1D
strain (Munn et al., 1991), there are no other reports of
mutations that are lethal in combination with chc1-ts al-
leles other than arf1D. This provides genetic support for
the substantial biochemical evidence in the literature im-
plicating ARF in clathrin recruitment to Golgi membranes
(Zhu et al., 1998, and references therein), and also pro-
vides validation for the arf1D synthetic lethal approach.
We were initially concerned about the specificity of the
drs2D–arf1D synthetic lethal interaction, even though four
alleles of the SWA3/DRS2 gene were recovered in this ge-
netic screen. However, from crosses with 19 different mu-
tants that perturb the secretory or endocytic pathways, we
found a specific interaction between pairwise combina-
tions of arf1D, drs2D, and chc1-ts alleles. The drs2D allele
was also synthetically lethal with pan1-20, an eps15-related
protein that interacts with yAP180 (yeast homologue of
clathrin assembly protein AP180) in a yeast two-hybrid as-
say (Wendland and Emr, 1998). Importantly, there was no
genetic interaction between drs2D and mutant ts alleles
encoding three different COPI subunits, even though com-
bination of arf1D with these COPI alleles produces a syn-
thetic growth defect (Gaynor et al., 1998). These results
suggest that Drs2p is specifically involved in clathrin, but
not COPI, function. This interpretation is supported by
the finding that membranes containing Drs2p could be
separated from early Golgi membranes where COPI
would be expected to function, and cofractionated with
late Golgi membranes where clathrin function is required.
Phenotypes Exhibited by the drs2D Mutant
These genetic analyses prompted us to examine the drs2D
mutant for defects in the secretory and endocytic path-
ways. The secretion kinetics and Golgi-specific glyco-
sylation of pro–a-factor and invertase were only modestly
perturbed. However, a substantial cold-sensitive defect in
the Kex2p-dependent processing of pro–a-factor was ob-
served. This resulted in secretion of the pro–a-factor pre-
cursor, a phenotype also exhibited by clathrin mutants
(Payne and Schekman, 1989). Kinetic defects were also
observed for CPY transport to the vacuole and the turn-
over of the Ste3p pheromone receptor within the vacuole.
These phenotypes are likely caused by a delay in endo-
some-to-vacuole transport that was clearly observed using
the fluorescent endocytic tracer FM4-64. Thus, the drs2D
mutation seems to specifically perturb late Golgi (TGN)
and endosome function.
As visualized by EM, the drs2D mutant accumulates ab-
normal membrane-bound structures that were morpholog-
ically equivalent to structures that accumulate in clathrin
mutants. The abnormal membrane structures that were
isolated from drs2D cells by differential centrifugation and
gel exclusion chromatography were enriched for a late
Golgi protein, but not for an endosomal marker protein.
Since the localization studies suggest that Drs2p is a late
Golgi (TGN) resident, these data strongly suggest that
Drs2p acts in the late Golgi to maintain normal structure
and function of this compartment. It is possible that Drs2p
has some function in the endosome as well, or the effect on
endosome function could be a secondary consequence of
perturbing late Golgi function.
Perhaps the most compelling evidence that Drs2p plays
a role in clathrin function is the striking difference in the
appearance of CCV preparations between drs2D and wild-
type cells. Very few bona fide CCVs could be isolated
from drs2D cells preincubated at the nonpermissive tem-
perature. These preparations contained clathrin baskets
and lattices with no associated membrane. In contrast,
CCV preparations from drs2D cells maintained at 308C
were indistinguishable from wild-type samples. These re-
sults suggest that Drs2p is required to form clathrin-coated
vesicles from Golgi membranes at temperatures below
238C. However, it is also possible that the association of
clathrin coats with vesicle membranes from drs2D cells is
less stable and the coat dissociates during cell lysis. In ei-
ther case, loss of Drs2p clearly perturbs CCVs.
At this time, it is not possible to distinguish whether the
effect of Drs2p on clathrin function is direct or a second-
ary consequence of the abnormal TGN structure. How-
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functions normally in the ability to sort vacuolar proteins
and in protein secretion, despite the abnormal morphol-
ogy. This suggests that late secretory vesicles bud normally
from the TGN in drs2D cells. The genetic interactions also
showed a high degree of specificity between drs2D and
clathrin mutations. Therefore, there is not a wholesale loss
of Golgi function in drs2D cells at the nonpermissive tem-
perature. Indeed, most of the specific defects observed can
be explained by a loss of clathrin function. Even the accu-
mulation of abnormal membrane at the permissive tem-
perature could be the result of inefficient CCV budding.
The temperature-conditional defects observed for a
strain carrying a complete loss of function allele is some-
what unusual. This suggests that Drs2p is required to over-
come an inherently cold-sensitive process in the cell (per-
haps CCV budding), such that the growth defect is caused
by the combination of low temperature and loss of Drs2p.
However, this cold-sensitive process is not at the extreme
of the normal growth range for yeast; drs2D cells fail to
grow at room temperature (208C) and the mutant pheno-
types described here are observed at this temperature. In
addition, some of the drs2D phenotypes, such as arf1D syn-
thetic lethality and abnormal Golgi morphology, are also
observed at 308C. Thus, it appears that Drs2p plays a role
in Golgi function at all temperatures examined but is only
essential below 238C. Alternatively, it is possible that
Drs2p function is essential at all temperatures, but loss of
Drs2p is compensated by one or more of the Drs2p-
related P-type ATPases at higher temperatures. In either
case, Drs2p clearly plays a critical role for organisms such
as yeast since the ability to adapt to daily fluctuations in
temperature is essential for their survival.
Potential Function of Drs2p as an
Aminophospholipid Translocase
What is the biochemical function of Drs2p? Many P-type
ATPases use the energy of ATP hydrolysis to pump cat-
ions such as Ca21, H1, Na1, or heavy metals across a mem-
brane against their electrochemical gradient. These trans-
porting ATPases contain signature motifs that allowed the
identification of 16 P-type ATPases in the yeast genome
that can be phylogenetically grouped into six distinct fami-
lies (Catty et al., 1997). Four of the families correspond to
the cation transporters just described, one family contains
two ORFs of unknown function, and the last family are
potential aminophospholipid transporters, which includes
Drs2p and four other uncharacterized ORFs. Drs2p is
28–35% identical to its four other yeast family members,
but is 47% identical to bovine or murine ATPase II from
chromaffin granules (FASTA comparisons), arguing that
Drs2p and ATPase II are orthologues. The closest related
P-type ATPases to the Drs2p family are the Ca21 trans-
porters (21% identity between Drs2p and Pmc1p). How-
ever, Drs2p and ATPase II are missing negatively charged
amino acids in transmembrane domains 4 and 6 that are
essential for cation transport and have hydrophobic resi-
dues in their place. This is consistent with the proposed
role of ATPase II and Drs2p in transporting aminophos-
pholipids and makes it less likely that Drs2p transports
cations.
The drs2D mutant has been reported to exhibit a defect
in the translocation of a fluorescent PS derivative across
the plasma membrane (Tang et al., 1996). However, Sieg-
mund et al. (1998) have recently challenged this observa-
tion and have failed to detect a difference between wild-
type and drs2D cells in the translocation of fluorescent
lipid derivatives across the plasma membrane. This group
also found no difference in the amount of PE exposed on
the outer leaflet of the plasma membrane as detected by
trinitrobenzene sulfonic acid labeling. These latter obser-
vations could suggest that Drs2p is not an aminophospho-
lipid translocase, but it is more likely that the Drs2p pro-
tein is simply not present at the plasma membrane and
therefore is not required to maintain an asymmetric dis-
tribution of aminophospholipids in this membrane. In
fact, we cannot detect Drs2p at the plasma membrane by
immunofluorescence localization or subcellular fraction-
ation (Figs. 7 and 8). Measurement of translocase activity
with Golgi membrane fractions is more complicated be-
cause the direction of flip is expected to be from the lumi-
nal to the cytoplasmic leaflet and thus requires incor-
poration of the probe into the luminal leaflet. Thus,
further work is required to determine if Drs2p is an ami-
nophospholipid translocase, as suggested by its homology
to ATPase II.
Since an aminophospholipid translocase activity is the
only biochemical function attributed to ATPase II and
Drs2p in the literature, it is relevant to speculate on how
membrane asymmetry may affect Golgi structure and
perhaps clathrin function. The bilayer couple hypothesis
of Sheetz and Singer (1974) proposes that asymmetric
changes in the two leaflets of a bilayer should induce con-
formational changes in the membrane. In fact, induced bi-
layer asymmetry can cause conversion of spherical lipo-
somes into tubular and interconnected vesicular structures
(Farge and Devaux, 1992). In this regard, it is possible that
changes in the asymmetric distribution of PS or PE could
influence the formation of tubules or fenestrated regions
of Golgi cisternae to produce a structure on which clathrin
can assemble more productively. This is consistent with
the morphological defect observed for Golgi membranes
in the drs2D mutant, which are notable for their lack of
fenestration or tubular regions. Particularly in comparison
to the arf1D mutant in which the Golgi is highly fenes-
trated or tubular in appearance (Gaynor et al., 1998).
Others have proposed that the transbilayer movement
of lipid could induce the bending of membranes to facili-
tate vesicle budding (Devaux, 1991). Zha et al. (1998) have
reported that changes in the composition of the plasma
membrane outer leaflet caused by sphingomyelinase treat-
ment can induce an energy-independent budding of func-
tional endocytic vesicles. In addition, Farge et al. (1999)
have recently reported that exogenous PS incorporated
into the external leaflet of the plasma membrane was
pumped to the inner leaflet and markedly enhanced the
level of bulk endocytosis. Thus, it is feasible that Drs2p
actively participates in CCV budding from Golgi mem-
branes, and becomes essential for this process as the tem-
perature drops below a specific threshold where a de-
creased fluidity of the membrane may prevent clathrin
from performing this function alone.
A third possibility is that an increase in the PE or PS
concentration of the cytoplasmic leaflet may influence theChen et al. Role for Drs2p in Late Golgi Function 1235
recruitment or activity of peripherally associated proteins.
For example, the association of an ARF guanine nucle-
otide exchange factor with Golgi membranes might be in-
fluenced by the PS concentration (Chardin et al., 1996). In
addition, clathrin can be recruited on chemically defined
liposomes, but requires an unusually high concentration of
PE (40% of total lipid) to produce well-defined clathrin-
coated buds on the membranes (Takei et al., 1998). One
might expect that an enzyme that pumps PE to the cyto-
plasmic membrane could produce a high local concentra-
tion of this lipid, particularly if the coat proteins restrict
lateral diffusion of PE. Purification and reconstitution of
Drs2p in chemically defined liposomes will help define the
biochemical function of this protein and perhaps shed light
on how Drs2p influences clathrin function in vivo.
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